Neurogene Inc. (NASDAQ:NGNE – Get Free Report) major shareholder Samsara Biocapital Gp, Llc acquired 48,770 shares of Neurogene stock in a transaction that occurred on Tuesday, November 26th. The shares were purchased at an average cost of $25.83 per share, with a total value of $1,259,729.10. Following the purchase, the insider now owns 1,717,127 shares […]